ESPERAS PHARMA
Esperas Pharma is a special purpose company created to develop one compound to proof-of-concept.
ESPERAS PHARMA
Social Links:
Founded:
2015-01-01
Address:
Montréal, Quebec, Canada
Country:
Canada
Total Employee:
1+
Status:
Active
Total Funding:
0
Similar Organizations
AurKa Pharma
AurKa Pharma Inc. is a special purpose company created to develop one compound to proof-of-concept.
BioLoomics
BioLoomics is a preclinical stage biotechnology company that develops drug discovery tools and protein drugs.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
Investors List
Fonds de solidarité FTQ
Fonds de solidarité FTQ investment in Venture Round - Esperas Pharma
TVM Capital Life Science
TVM Capital Life Science investment in Venture Round - Esperas Pharma
More informations about "Esperas Pharma"
Esperas Pharma - Crunchbase Company Profile & Funding
Esperas Pharma is located in Montréal, Quebec, Canada. Who invested in Esperas Pharma? Esperas Pharma has 2 investors including Fonds de solidarité FTQ and TVM Capital Life …See details»
In partnership with Q-CROC, Esperas will invest up to $7M in a …
MONTREAL, April 11, 2016 /CNW Telbec/ – Esperas Pharma Inc. (“Esperas”) today announced the initiation of a project to develop a new oral anticancer agent called ESP-01, in partnership …See details»
Esperas Pharma Inc. will begin clinical development of …
MONTREAL, April 11, 2016 /CNW Telbec/ - Esperas Pharma Inc. ("Esperas") today announced the initiation of a project to develop a new oral anticancer …See details»
Esperas Pharma Inc. - TVM Capital Life Science Venture …
Esperas Pharma Inc., Montréal, is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Innovation I L.P. and Fonds de solidarité FTQ. Esperas Pharma Inc. …See details»
Esperas Pharma Inc. Company Profile | Montréal, QC, Canada ...
Find company research, competitor information, contact details & financial data for Esperas Pharma Inc. of Montréal, QC. Get the latest business insights from Dun & Bradstreet.See details»
Esperas Pharma - PitchBook
Esperas Pharma General Information Description. Operator of a medical technology platform intended to offer biopharmaceutical products. The company's platform engages in developing …See details»
Esperas Pharma Inc. will begin clinical development of a new anti ...
Apr 14, 2016 Montréal, Québec, April 11 2016 – Esperas Pharma Inc. (“Esperas”) today announced the initiation of a project to develop a new oral anticancer agent called ESP-01, in …See details»
Esperas Pharma, Inc. Announces Investment from TVM …
Feb 21, 2023 About Esperas Pharma, Inc. Esperas Pharma, Inc. is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Innovation I and ...See details»
Esperas Pharma Inc. - Drug pipelines, Patents, Clinical trials
Nov 1, 2024 Esperas Pharma, Inc. is led by an experienced management team. The company has completed: 1) dose-escalations of ESP-001 monotherapy and in combination with …See details»
New anti-cancer agent to be commercialized in Quebec partnership
Apr 12, 2016 Montreal, QC – Esperas Pharma is partnering with Quebec Clinical Research Organization in Cancer (Q-CROC) in a project to develop a new oral anticancer agent called …See details»
Esperas Pharma, Inc. Announces Investment from TVM Life Science ...
Feb 21, 2023 Esperas Pharma, Inc. is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM Life Science Innovation I …See details»
In partnership with Q-CROC, Esperas will invest up to $7M in a …
MONTREAL, April 11, 2016 /CNW Telbec/ - Esperas Pharma Inc. ("Esperas") today announced the initiation of a project to develop a new oral anticancer agent called ESP-01, in partnership …See details»
Esperas Pharma - Products, Competitors, Financials, Employees ...
Esperas Pharma is a special-purpose company created to develop one compound for proof-of-concept. The company develops medical science and research and development of medical …See details»
ESP-001 - Drug Targets, Indications, Patents - Synapse - Patsnap
Esperas Pharma, Inc. is led by an experienced management team. The company has completed: 1) dose-escalations of ESP-001 monotherapy and in combination with gemcitabine; and 2) …See details»
Esperas Pharma, Inc. Announces Investment from TVM Life Science ...
Montréal, Québec, February 21, 2023 – Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM Capital Life Science …See details»
Esperas Pharma, Inc. Announces Investment from TVM Life Science ...
Montréal, Québec, February 21, 2023 – Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM Capital Life Science …See details»
Esperas Pharma, Inc. Announces Investment from TVM Life Science ...
Feb 21, 2023 About Esperas Pharma, Inc. Esperas Pharma, Inc. is a special purpose company created to develop one compound to proof-of-concept. The project is fully financed by TVM …See details»
Esperas Pharma, Inc. Announces Investment from TVM Life Science ...
MONTRÉAL, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM …See details»
Esperas Pharma, Inc. Announces Investment from TVM Life
MONTRÉAL, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Esperas Pharma, Inc. (“Esperas”), a company based in Montréal, Québec, today announced a follow-on investment by TVM …See details»
LY-2880070 - Drug Targets, Indications, Patents - Synapse
Esperas Pharma, Inc. is led by an experienced management team. The company has completed: 1) dose-escalations of ESP-001 monotherapy and in combination with gemcitabine; and 2) …See details»